The CFTR modulators IVA, LUM/IVA, TEZ/IVA, and ELX/TEZ/IVA have been shown to be effective not just in people with mild to severe CF, but even in people with advanced pulmonary disease, such as lung transplant applicants. The gene discussed is CFTR; the disease is cystic fibrosis.